Table I.
Characteristics of 107 studied hepatitis C patients with liver cirrhosis.
| Characteristic | Value |
|---|---|
| Number of patients | 107 |
| Age (years), median (IQR) | 62.5 (13.3) |
| Gender, n (%) | |
| Male | 54 (51) |
| Female | 53 (49) |
| Height (m), median (IQR) | 1.58 (0.2) |
| Weight (kg), median (IQR) | 56.4 (13.3) |
| BMI (kg/m2), median (IQR) | 22.6 (4.2) |
| Alcohol consumption, n (%) | |
| Excessive | 11 (10) |
| Not excessive | 96 (90) |
| Diabetes mellitus, n (%) | |
| + | 44 (41) |
| - | 63 (59) |
| Diagnosis, n (%) | |
| Histological | 80 (75) |
| Clinical | 27 (25) |
| Child-Pugh grade, n (%) | |
| A | 56 (52) |
| B | 44 (41) |
| C | 7 (7) |
| Platelet count (103/μl), median (IQR) | 100 (6.5) |
| AST (IU/l), median (IQR) | 71 (64) |
| ALT (IU/l), median (IQR) | 60 (61) |
| γ-GTP (IU/l), median (IQR) | 45 (58) |
| Bilirubin (mg/dl), median (IQR) | 1.0 (0.9) |
| Albumin (mg/dl), median (IQR) | 3.8 (0.9) |
| TC (mg/dl), median (IQR) | 152 (44) |
| TG (mg/dl), median (IQR) | 92 (57 |
| AFP (ng/ml), median (IQR) | 11 (24) |
| <6, n (%) | 34 (32) |
| 6–19, n (%) | 38 (35) |
| ≥20, n (%) | 35 (33) |
| BCAA, n (%) | |
| + | 39 (36) |
| - | 68 (64) |
| Interferon therapy, n (%) | |
| SVR | 11 (10) |
| Non-SVR | 32 (30) |
| No therapy | 64 (60) |
Data are median (IQR) or frequency (%). BMI, body mass index; AST, aspartate transaminase; ALT, alanine transaminase; TC, total cholesterol; TG, triglyceride; BCAA, branched-chain amino acids; AFP, α-fetoprotein; SVR, sustained virological response.